Deal round-up 20/03/02

Elron leads $30m Galil investment; 3i signs £4m technology deal; 2M completes SimCorp partial exit

Elron leads $30m Galil investment

Israeli holding company Elron Electronic Industries, an eight percent shareholder in Galil Medical, has led a $30m financing round for Galil. Galil, which develops equipment for minimally invasive treatment for cancer, has to date raised $11.5m in two previous fund-raising rounds.

The latest fund-raising, which involved several undisclosed venture capital companies, follows $56m raised by Israeli chipmaker Mellanox Technologies and $75m raised by optical communications start-up Atrica in February.

3i signs £4m technology deal

3i has led a £4m second round investment in MicroEmissive Displays, an early-stage Scottish technology company developing tiny screens for cameras and camcorders.

The funding round of MED, a spin out from Edinburgh and Napier universities, involves a £2m investment from 3i with additional investment from Scottish Equity Partners, which will contribute £1m, and EVP, which is to commit £1m of venture.

2M completes SimCorp partial exit

2M Invest has sold 100,000 shares in SimCorp, corresponding to 2 per cent of SimCorp's total share capital. Proceeds from the sale are E4.17m and the gain totals E3.76m. Following the sale, 2M Invest holds 565,200 shares in SimCorp.

The sale has been made as part of 2M Invest’s strategy not to hold shares in listed companies as investments. The total proceeds from the sale will be used to reduce the company's bank debt.